[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2018 [#1]

Announcement Date
16-May-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Mar-2018 [#1]
Profit Trend
QoQ- -67.33%
YoY- -7.07%
Quarter Report
View:
Show?
Cumulative Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 2,384,956 1,788,312 1,200,652 617,923 2,323,960 1,710,764 1,136,261 63.71%
PBT 70,220 58,280 40,677 28,707 73,064 53,198 37,927 50.61%
Tax -26,990 -19,620 -17,322 -11,118 -17,977 -20,299 -8,918 108.80%
NP 43,230 38,660 23,355 17,589 55,087 32,899 29,009 30.37%
-
NP to SH 42,468 38,031 22,980 17,586 53,823 32,023 28,443 30.53%
-
Tax Rate 38.44% 33.67% 42.58% 38.73% 24.60% 38.16% 23.51% -
Total Cost 2,341,726 1,749,652 1,177,297 600,334 2,268,873 1,677,865 1,107,252 64.53%
-
Net Worth 509,862 522,618 519,642 524,838 526,888 531,892 541,894 -3.96%
Dividend
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Div 41,621 36,401 23,383 12,991 49,314 33,729 20,742 58.88%
Div Payout % 98.01% 95.71% 101.76% 73.87% 91.62% 105.33% 72.93% -
Equity
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Net Worth 509,862 522,618 519,642 524,838 526,888 531,892 541,894 -3.96%
NOSH 260,505 260,505 259,821 259,821 259,821 259,821 259,279 0.31%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 1.81% 2.16% 1.95% 2.85% 2.37% 1.92% 2.55% -
ROE 8.33% 7.28% 4.42% 3.35% 10.22% 6.02% 5.25% -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 916.82 687.79 462.11 237.83 895.38 659.36 438.24 63.35%
EPS 16.33 14.63 8.84 6.77 20.74 12.34 10.97 30.27%
DPS 16.00 14.00 9.00 5.00 19.00 13.00 8.00 58.53%
NAPS 1.96 2.01 2.00 2.02 2.03 2.05 2.09 -4.17%
Adjusted Per Share Value based on latest NOSH - 259,821
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 165.48 124.08 83.31 42.87 161.25 118.70 78.84 63.71%
EPS 2.95 2.64 1.59 1.22 3.73 2.22 1.97 30.79%
DPS 2.89 2.53 1.62 0.90 3.42 2.34 1.44 58.90%
NAPS 0.3538 0.3626 0.3605 0.3642 0.3656 0.369 0.376 -3.96%
Price Multiplier on Financial Quarter End Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 -
Price 2.78 2.89 2.88 4.28 4.60 4.14 4.58 -
P/RPS 0.30 0.42 0.62 1.80 0.51 0.63 1.05 -56.52%
P/EPS 17.03 19.76 32.56 63.23 22.18 33.54 41.75 -44.90%
EY 5.87 5.06 3.07 1.58 4.51 2.98 2.40 81.23%
DY 5.76 4.84 3.13 1.17 4.13 3.14 1.75 120.79%
P/NAPS 1.42 1.44 1.44 2.12 2.27 2.02 2.19 -25.02%
Price Multiplier on Announcement Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 15/11/17 16/08/17 -
Price 2.76 3.09 3.11 4.07 4.04 3.82 4.19 -
P/RPS 0.30 0.45 0.67 1.71 0.45 0.58 0.96 -53.85%
P/EPS 16.91 21.13 35.16 60.13 19.48 30.95 38.20 -41.83%
EY 5.92 4.73 2.84 1.66 5.13 3.23 2.62 71.93%
DY 5.80 4.53 2.89 1.23 4.70 3.40 1.91 109.27%
P/NAPS 1.41 1.54 1.56 2.01 1.99 1.86 2.00 -20.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment